On today's episode of This Changes Things hosts Baker Machado and Hope King give a recap of the day's top earnings. In addition, they talk through top tips to ensure your business is a success. But first, Jason Mayden, CEO and Co-Founder of Super Heroic, joins This Changes Things to discuss how creativity can empower an entire generation. He spent 13 years working for Nike, leading the creation of products for athletes and cultural icons such as Michael Jordan, Carmelo Anthony, and Derek Jeter. At Super Heroic it's his mission to empower children with the power of play through different products. Plus, everyone has those quirky tendencies, but how do we hone in those attributions and create innovation? Melissa Schilling, Author of "Quirky" and Lydia Dishman, Reporter at Fast Company join This Changes Things to discuss different strategies to becoming a great leader.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More